10X GENOMICS Debt To Equity vs. Current Ratio
| 1KJ Stock | EUR 12.61 0.07 0.56% |
For 10X GENOMICS profitability analysis, we use financial ratios and fundamental drivers that measure the ability of 10X GENOMICS to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well 10X GENOMICS DL utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between 10X GENOMICS's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of 10X GENOMICS DL over time as well as its relative position and ranking within its peers.
10X |
10X GENOMICS DL Current Ratio vs. Debt To Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining 10X GENOMICS's current stock value. Our valuation model uses many indicators to compare 10X GENOMICS value to that of its competitors to determine the firm's financial worth. 10X GENOMICS DL is rated below average in debt to equity category among its peers. It is rated fourth in current ratio category among its peers fabricating about 74.33 of Current Ratio per Debt To Equity. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the 10X GENOMICS's earnings, one of the primary drivers of an investment's value.10X Current Ratio vs. Debt To Equity
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
10X GENOMICS |
| = | 0.09 % |
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
10X GENOMICS |
| = | 6.69 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
10X Current Ratio Comparison
10X GENOMICS is rated third in current ratio category among its peers.
10X GENOMICS Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in 10X GENOMICS, profitability is also one of the essential criteria for including it into their portfolios because, without profit, 10X GENOMICS will eventually generate negative long term returns. The profitability progress is the general direction of 10X GENOMICS's change in net profit over the period of time. It can combine multiple indicators of 10X GENOMICS, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California. 10X GENOMICS operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 852 people.
10X Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on 10X GENOMICS. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of 10X GENOMICS position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the 10X GENOMICS's important profitability drivers and their relationship over time.
Use 10X GENOMICS in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if 10X GENOMICS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 10X GENOMICS will appreciate offsetting losses from the drop in the long position's value.10X GENOMICS Pair Trading
10X GENOMICS DL Pair Trading Analysis
The ability to find closely correlated positions to 10X GENOMICS could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace 10X GENOMICS when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back 10X GENOMICS - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling 10X GENOMICS DL to buy it.
The correlation of 10X GENOMICS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as 10X GENOMICS moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if 10X GENOMICS DL moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for 10X GENOMICS can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your 10X GENOMICS position
In addition to having 10X GENOMICS in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Driverless Cars Thematic Idea Now
Driverless Cars
It encompasses large technology companies, automotive makers, security firms, and thematic ETFs across multiple industries. These entities are directly or indirectly involved in shaping the development and marketing of self-driving vehicles. The Driverless Cars theme has 36 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Driverless Cars Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in 10X Stock
To fully project 10X GENOMICS's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of 10X GENOMICS DL at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include 10X GENOMICS's income statement, its balance sheet, and the statement of cash flows.